J. V. Teichmann scite author profile

No statistically significant differences in treatment efficacy were detected between 20 Gy IF radiotherapy and 1X (COPP + ABVD) chemotherapy following CR after six cycles of alternating chemotherapy in patients with advanced-stage HD. However, limited observations in a non-randomized cohort indicate that patients without consolidation treatment of CR after 6 cycles of chemotherapy may have an elevated risk of relapse.

show abstract

Risk Factor Adapted Treatment of Hodgkin’s Lymphoma: Strategies and Perspectives

Loeffler¹,

Pfreundschuh²,

Rühl³

et al. 1989

View full text Add to dashboard Cite

Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia—Case report and review of the literature

et al. 1986

View full text Add to dashboard Cite

Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease

Loeffler¹,

Diehl²,

Pfreundschuh³

et al. 1998

Cancer/Radiothérapie

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

J. V. Teichmann

Incidence and Prognostic Significance of Immunophenotypic Subgroups in Childhood Acute Lymphoblastic Leukemia: Experience of the BFM Study 86

Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease

Risk Factor Adapted Treatment of Hodgkin’s Lymphoma: Strategies and Perspectives

Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia—Case report and review of the literature

Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease

Contact Info

Product

Resources

About